Compare $IMNM vs $VERA | Chartloom

Compare

$IMNM vs $VERA

Immunome Inc · Vera Therapeutics, Inc

IMNM

Immunome Inc

VERA

Vera Therapeutics, Inc

Compare $IMNM vs $VERA

Comparing Immunome Inc and Vera Therapeutics, Inc

IMNMImmunome Inc

VERAVera Therapeutics, Inc

IMNMImmunome Inc

Market cap

$2.21B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

127.50x

Rev growth (TTM)

-100.0%

YTD performance

-6.1%

52W performance

39.5%

FCF yield

-10.3%

VERAVera Therapeutics, Inc

Market cap

$2.14B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

19.87x

Rev growth (TTM)

—

YTD performance

-38.5%

52W performance

-2.0%

FCF yield

-15.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMNM

VERA

Detailed metrics comparison

IMNM

Immunome Inc

VERA

Vera Therapeutics, Inc

Market Cap

IMNM$2.21B

VERA$2.14B

Enterprise Value

IMNM$2.00B

VERA$2.17B

Price

IMNM$19.55

VERA$29.88

P/E Ratio

IMNMN/A

VERAN/A

P/S Ratio

IMNM188.56x

VERA0.00x

EV/Sales

IMNM171.27x

VERA0.00x

EV/EBITDA

IMNM0.00x

VERA0.00x

P/B Ratio

IMNM4.52x

VERA5.38x

P/FCF Ratio

IMNMN/A

VERAN/A

EV/FCF

IMNM-8.75x

VERA-6.40x

PEG Ratio

IMNMN/A

VERAN/A

Forward P/E (NTM)

IMNMN/A

VERAN/A

Forward P/S (NTM)

IMNM127.50x

VERA19.87x

Revenue (TTM)

IMNM$0

VERA$0

Revenue Growth (YoY)

IMNM-100.0%

VERAN/A

Forward Rev Growth

IMNM15247.2%

VERA698.6%

Gross Margin (TTM)

IMNM0.0%

VERA0.0%

Operating Margin (TTM)

IMNM0.0%

VERA0.0%

EBITDA Margin (TTM)

IMNM0.0%

VERA0.0%

Net Margin (TTM)

IMNM0.0%

VERA0.0%

FCF Margin (TTM)

IMNMN/A

VERAN/A

Net Income (TTM)

IMNM$-254M

VERA$-402M

FCF (TTM)

IMNM$-228M

VERA$-339M

EPS (TTM)

IMNM-$2.25

VERA-$5.59

ROE (TTM)

IMNM-5056.0%

VERA-8413.0%

ROA (TTM)

IMNM-4693.0%

VERA-6679.0%

ROIC (TTM)

IMNM-5056.0%

VERA-7272.0%

Cash

IMNM$218M

VERA$49M

Debt

IMNM$0

VERA$75M

Net Cash/Debt

IMNM$218M

VERA$-26M

Current Ratio (TTM)

IMNM15.08x

VERA10.92x

Quick Ratio (TTM)

IMNM14.56x

VERA10.50x

Debt/Equity (TTM)

IMNM0.00x

VERA0.18x

Debt/Assets (TTM)

IMNM0.0%

VERA0.0%

Interest Coverage (TTM)

IMNMN/A

VERAN/A

Net Debt/EBITDA (TTM)

IMNM0.00x

VERA0.00x

Beta

IMNM2.65

VERA1.13

52W Performance

IMNM39.5%

VERA-2.0%

YTD Performance

IMNM-6.1%

VERA-38.5%

% from 52W High

IMNM-35.0%

VERA-46.7%

% from 52W Low

IMNM44.9%

VERA29.6%

Asset Turnover (TTM)

IMNM0.04x

VERA0.00x

FCF Yield (TTM)

IMNM-10.3%

VERA-15.8%

Earnings Yield (TTM)

IMNM-11.5%

VERA-18.7%

Dividend Yield (TTM)

IMNMN/A

VERAN/A

Rule of 40

IMNM-100.0

VERA0.0

EV/GP/RG

IMNMN/A

VERAN/A

Ticker research

View IMNM research View VERA research

Metric	IMNM Immunome Inc	VERA Vera Therapeutics, Inc
Market & Valuation
Market Cap	$2.21B	$2.14B
Enterprise Value	$2.00B	$2.17B
Price	$19.55	$29.88
P/E Ratio	N/A	N/A
P/S Ratio	188.56x	0.00x
EV/Sales	171.27x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.52x	5.38x
P/FCF Ratio	N/A	N/A
EV/FCF	-8.75x	-6.40x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	127.50x	19.87x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	15247.2%	698.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-254M	$-402M
FCF (TTM)	$-228M	$-339M
EPS (TTM)	-$2.25	-$5.59
ROE (TTM)	-5056.0%	-8413.0%
ROA (TTM)	-4693.0%	-6679.0%
ROIC (TTM)	-5056.0%	-7272.0%
Financial Health
Cash	$218M	$49M
Debt	$0	$75M
Net Cash/Debt	$218M	$-26M
Current Ratio (TTM)	15.08x	10.92x
Quick Ratio (TTM)	14.56x	10.50x
Debt/Equity (TTM)	0.00x	0.18x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.65	1.13
52W Performance	39.5%	-2.0%
YTD Performance	-6.1%	-38.5%
% from 52W High	-35.0%	-46.7%
% from 52W Low	44.9%	29.6%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.00x
FCF Yield (TTM)	-10.3%	-15.8%
Earnings Yield (TTM)	-11.5%	-18.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IMNM research	View VERA research

Valuation

P/S Ratio

VERA

0.00x

IMNM

188.56x

EV/FCF

IMNM

-8.75x

VERA

-6.40x

Growth & revenue

Revenue Growth TTM

IMNM

-100.0%

Forward Revenue Growth

IMNM

15247.2%

VERA

698.6%

Profitability & performance

Gross Margin

IMNM

0.0%

VERA

0.0%

ROE

IMNM

-5056.0%

VERA

-8413.0%

FCF Yield %

IMNM

-10.3%

VERA

-15.8%

52-Week Performance

IMNM

39.5%

VERA

-2.0%

Detailed metrics comparison

IMNM

Immunome Inc

VERA

Vera Therapeutics, Inc

Market Cap

IMNM$2.21B

VERA$2.14B

Enterprise Value

IMNM$2.00B

VERA$2.17B

Price

IMNM$19.55

VERA$29.88

P/E Ratio

IMNMN/A

VERAN/A

P/S Ratio

IMNM188.56x

VERA0.00x

EV/Sales

IMNM171.27x

VERA0.00x

EV/EBITDA

IMNM0.00x

VERA0.00x

P/B Ratio

IMNM4.52x

VERA5.38x

P/FCF Ratio

IMNMN/A

VERAN/A

EV/FCF

IMNM-8.75x

VERA-6.40x

PEG Ratio

IMNMN/A

VERAN/A

Forward P/E (NTM)

IMNMN/A

VERAN/A

Forward P/S (NTM)

IMNM127.50x

VERA19.87x

Revenue (TTM)

IMNM$0

VERA$0

Revenue Growth (YoY)

IMNM-100.0%

VERAN/A

Forward Rev Growth

IMNM15247.2%

VERA698.6%

Gross Margin (TTM)

IMNM0.0%

VERA0.0%

Operating Margin (TTM)

IMNM0.0%

VERA0.0%

EBITDA Margin (TTM)

IMNM0.0%

VERA0.0%

Net Margin (TTM)

IMNM0.0%

VERA0.0%

FCF Margin (TTM)

IMNMN/A

VERAN/A

Net Income (TTM)

IMNM$-254M

VERA$-402M

FCF (TTM)

IMNM$-228M

VERA$-339M

EPS (TTM)

IMNM-$2.25

VERA-$5.59

ROE (TTM)

IMNM-5056.0%

VERA-8413.0%

ROA (TTM)

IMNM-4693.0%

VERA-6679.0%

ROIC (TTM)

IMNM-5056.0%

VERA-7272.0%

Cash

IMNM$218M

VERA$49M

Debt

IMNM$0

VERA$75M

Net Cash/Debt

IMNM$218M

VERA$-26M

Current Ratio (TTM)

IMNM15.08x

VERA10.92x

Quick Ratio (TTM)

IMNM14.56x

VERA10.50x

Debt/Equity (TTM)

IMNM0.00x

VERA0.18x

Debt/Assets (TTM)

IMNM0.0%

VERA0.0%

Interest Coverage (TTM)

IMNMN/A

VERAN/A

Net Debt/EBITDA (TTM)

IMNM0.00x

VERA0.00x

Beta

IMNM2.65

VERA1.13

52W Performance

IMNM39.5%

VERA-2.0%

YTD Performance

IMNM-6.1%

VERA-38.5%

% from 52W High

IMNM-35.0%

VERA-46.7%

% from 52W Low

IMNM44.9%

VERA29.6%

Asset Turnover (TTM)

IMNM0.04x

VERA0.00x

FCF Yield (TTM)

IMNM-10.3%

VERA-15.8%

Earnings Yield (TTM)

IMNM-11.5%

VERA-18.7%

Dividend Yield (TTM)

IMNMN/A

VERAN/A

Rule of 40

IMNM-100.0

VERA0.0

EV/GP/RG

IMNMN/A

VERAN/A

Ticker research

View IMNM research View VERA research

Metric	IMNM Immunome Inc	VERA Vera Therapeutics, Inc
Market & Valuation
Market Cap	$2.21B	$2.14B
Enterprise Value	$2.00B	$2.17B
Price	$19.55	$29.88
P/E Ratio	N/A	N/A
P/S Ratio	188.56x	0.00x
EV/Sales	171.27x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.52x	5.38x
P/FCF Ratio	N/A	N/A
EV/FCF	-8.75x	-6.40x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	127.50x	19.87x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	15247.2%	698.6%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-254M	$-402M
FCF (TTM)	$-228M	$-339M
EPS (TTM)	-$2.25	-$5.59
ROE (TTM)	-5056.0%	-8413.0%
ROA (TTM)	-4693.0%	-6679.0%
ROIC (TTM)	-5056.0%	-7272.0%
Financial Health
Cash	$218M	$49M
Debt	$0	$75M
Net Cash/Debt	$218M	$-26M
Current Ratio (TTM)	15.08x	10.92x
Quick Ratio (TTM)	14.56x	10.50x
Debt/Equity (TTM)	0.00x	0.18x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.65	1.13
52W Performance	39.5%	-2.0%
YTD Performance	-6.1%	-38.5%
% from 52W High	-35.0%	-46.7%
% from 52W Low	44.9%	29.6%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.00x
FCF Yield (TTM)	-10.3%	-15.8%
Earnings Yield (TTM)	-11.5%	-18.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View IMNM research	View VERA research